Mast Cells and Its Proteases in COPD — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Mast Cells and Its Proteases in COPD — Stella

Recruiting

Back to COPD Exacerbation trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Russia

Voronezh State Medical University, Voronezh

Key details

Sponsor

Voronezh N.N. Burdenko State Medical Academy

Enrollment target

~30 participants

Started

January 2019

Primary completion

August 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

20 Years – 70 Years

Last updated April 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov